One drug at a time: new study aims to cut bleeding risk in heart patients
NCT ID NCT05955365
First seen May 13, 2026 · Last updated May 13, 2026
Summary
This study tests a new approach for people with atrial fibrillation (an irregular heartbeat) who receive a heart stent. Instead of taking multiple blood thinners together for months, participants will take just one drug at a time: an antiplatelet for the first month, then a different blood thinner long-term. The goal is to see if this simpler plan lowers the risk of serious bleeding while still preventing strokes and heart attacks. About 3,010 adults will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION (AF) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHU Nîmes
NOT_YET_RECRUITINGNîmes, 30029, France
Contact Email: •••••@•••••
-
Cardiocentro Ticino Institute
RECRUITINGLugano, Canton Ticino, 6900, Switzerland
Contact Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hartcentrum Hasselt
NOT_YET_RECRUITINGHasselt, 3500, Belgium
Contact Email: •••••@•••••
-
Hospital Universitario Marques de Valdecilla
NOT_YET_RECRUITINGSantander, 39008, Spain
Contact Email: •••••@•••••
-
Hôpitaux Universitaires de Genève
RECRUITINGGeneva, 1211, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
IRCCS Humanitas
NOT_YET_RECRUITINGMilan, Rozzano, 20089, Italy
Contact Email: •••••@•••••
-
Imperial College London
NOT_YET_RECRUITINGLondon, SW7 2AZ, United Kingdom
Contact Email: •••••@•••••
-
Inselspital, Bern University Hospital, Department of Cardiology
RECRUITINGBern, 3010, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Klinikum Friedrichshafen
NOT_YET_RECRUITINGFriedrichshafen, 88048, Germany
Contact Email: •••••@•••••
-
Ospedale Ferrarotto
NOT_YET_RECRUITINGCatania, Catania CT, 95124, Italy
Contact Email: •••••@•••••
-
UMC public
NOT_YET_RECRUITINGAmsterdam, 1081, Netherlands
Contact Email: •••••@•••••
-
University Hospital Zürich
RECRUITINGZurich, 8091, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Universitätsklinikum Frankfurt/Main
NOT_YET_RECRUITINGFrankfurt am Main, 60590, Germany
Contact Email: •••••@•••••
-
Universitätsspital Basel
RECRUITINGBasel, 4031, Switzerland
Contact Email: •••••@•••••
Contact Email: •••••@•••••
-
Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu
NOT_YET_RECRUITINGPoznan, 61-701, Poland
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.